Gene: METAP1D
Official Full Name: methionyl aminopeptidase type 1D, mitochondrialprovided by HGNC
Gene Summary: The N-terminal methionine excision pathway is an essential process in which the N-terminal methionine is removed from many proteins, thus facilitating subsequent protein modification. In mitochondria, enzymes that catalyze this reaction are celled methionine aminopeptidases (MetAps, or MAPs; EC 3.4.11.18) (Serero et al., 2003 [PubMed 14532271]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21186 | METAP1D Knockout cell line (HeLa) | Human | METAP1D | 1:3~1:6 | Negative | Online Inquiry |
KO21187 | METAP1D Knockout cell line (HCT 116) | Human | METAP1D | 1:2~1:4 | Negative | Online Inquiry |
KO21188 | METAP1D Knockout cell line (HEK293) | Human | METAP1D | 1:3~1:6 | Negative | Online Inquiry |
KO21189 | METAP1D Knockout cell line (A549) | Human | METAP1D | 1:3~1:4 | Negative | Online Inquiry |
METAP1D Gene Knockout Cell Lines are engineered cellular models that have undergone targeted gene disruption to elucidate the role of the METAP1D gene in various biological processes. These knockout cell lines are invaluable tools for researchers focusing on gene function, cellular signaling, and disease pathways, primarily involving translational control and the regulation of protein maturation.
The METAP1D gene encodes for methionine aminopeptidase 1D, an enzyme responsible for the removal of the initiator methionine from nascent proteins, which is crucial for proper protein folding and function. By employing CRISPR/Cas9 technology, METAP1D Gene Knockout Cell Lines exhibit a complete absence of functional METAP1D protein, enabling researchers to investigate the downstream effects of this alteration on cellular metabolism, proliferation, and response to therapeutic agents.
The scientific importance of these cell lines lies in their ability to create a controlled environment that mimics specific mutations or gene deletions found in human diseases, thus facilitating translational research. They serve as essential models for drug discovery, toxicology studies, and the development of targeted therapies, particularly in the areas of cancer and neurodegeneration, where METAP1D has been implicated.
Compared to conventional knockout models, METAP1D Gene Knockout Cell Lines offer several advantages, including enhanced precision in gene editing, reproducibility of results, and compatibility with high-throughput screening methods. Furthermore, these cell lines are designed for easy integration into various experimental workflows, allowing for versatile applications in both basic and applied research.
For researchers and clinicians, the use of METAP1D Gene Knockout Cell Lines is invaluable. They provide clear insights into the role of METAP1D in health and disease, thereby contributing to more informed therapeutic strategies. With an established track record in producing high-quality biological products, our company is dedicated to supporting scientific inquiry and innovation. We are committed to providing researchers with the high-fidelity models needed to advance our understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.